Resolving erroneous reports in toxicology and therapeutic drug monitoring a comprehensive guide /
I tiakina i:
Kaituhi matua: | |
---|---|
Kaituhi rangatōpū: | |
Hōputu: | Tāhiko īPukapuka |
Reo: | Ingarihi |
I whakaputaina: |
Hoboken, N.J. :
John Wiley & Sons,
c2012.
|
Ngā marau: | |
Urunga tuihono: | An electronic book accessible through the World Wide Web; click to view |
Ngā Tūtohu: |
Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
Rārangi ihirangi:
- An introduction to tests performed in toxicology laboratories and methodologies available for such testings
- Challenges in drugs of abuse testing
- False positive results in immunoassays for drugs of abuse testing
- True positive drugs of abuse test results due to prescription and non-prescription drugs
- When toxicology report is negative in a suspected overdosed patient : the world of designer drugs
- Abuse of magic mushroom, peyote cactus and solvent : no readily available laboratory tests
- False positive alcohol tests using breath analyzers and automated analyzers
- Role of laboratory in detecting other poisoning including pesticides, ethylene glycol, and methanol
- Poisoning with warfarin and superwarfarin : what laboratory can do?
- Plant poisoning and clinical laboratory
- Sources of erroneous results in therapeutic drug monitoring due to pre-analytical errors, high bilirubin, hemolysis, and heterophilic antibody
- Interferences in immunoassays used for digoxin monitoring
- Interferences in immunoassays used for monitoring anticonvulsants and usefulness of monitoring free anticonvulsants in certain patients
- Interferences in immunoassays used for monitoring tricyclic antidepressant
- Therapeutic drug monitoring of immunosuppressant drugs : limitations of immunoassays and need for chromatographic methods
- Effect of drug-herb interactions on therapeutic drug monitoring
- Pharmacogenomics and toxicology laboratory
- Approaches for eliminating interference/discordant specimen in therapeutic drug monitoring and drugs of abuse testing.